Fradimycin B
CAS: 1429166-72-2
Ref. 3D-EHC16672
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Información del producto
Fradimycin B is an anticancer drug that belongs to a class of human kinase inhibitors. It has been shown to be effective against a variety of cancer cells, including those resistant to other treatments. Fradimycin B works by inhibiting the activity of kinases, which are proteins that play a key role in cell growth and division. This inhibition leads to apoptosis, or programmed cell death, in cancer cells. Fradimycin B has also been found in Chinese medicinal urine and has potential therapeutic applications for the treatment of tumors. Additionally, it has been studied in combination with sertraline as a potential cancer therapy. Overall, Fradimycin B shows promise as a potent inhibitor of cancer cell proliferation and survival.
Propiedades químicas
Consulta técnica sobre: 3D-EHC16672 Fradimycin B
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
